Although the 2026 American Society of Clinical Oncology (ASCO) meeting is over for another year, the editorial team Clinical Trials Arena is still excited about all the potentially groundbreaking results presented at the conference, with both up-and-coming biotech companies and big pharma players sharing some exciting data.
Over the five-day event, participants gathered to learn about the latest advances in their disease areas, with data presented on hematological malignancies such as multiple myeloma, as well as solid tumors such as non-small cell lung cancer (NSCLC) and pancreatic cancer.
ASCO 2026 focused on next-generation therapies, particularly drugs such as antibody-drug conjugates (ADCs), cancer vaccines, and cell and gene therapies. in vivo (CGT) and bispecific antibodies. These drugs are coming to the forefront as cancer treatments become increasingly complex, and combination approaches combining targeted therapy and chemotherapy are becoming the norm.
In this episode of the GlobalData Healthcare Podcast, reporter Annabelle Cartal-Allen welcomes GlobalData Senior Oncology Analysts and ASCO 2026 attendees Jack Cuthbertson and Selena Yu. Together, they discuss the conference's highlights, both in the newsroom and on the exhibit floor, while Jack and Selena reflect on their busy schedule at ASCO and what they believe generated the most excitement.
Jack and Selena also share three of the most exciting research findings, detailing how these data could impact the future of the oncology sector, and whether some of the highly anticipated presentations lived up to expectations.
If you enjoyed this podcast, you may want to check out our Spotify page, where we cover a wide range of topics in medtech, pharma, biotech, and healthcare.
The ASCO26: Insights into Top Findings and Key Trends podcast was originally produced and published by Clinical Trials Arena, a GlobalData brand.
The information on this website is provided in good faith and is for general informational purposes only. It is not intended to constitute advice on which you should rely, and we make no representations, warranties, or promises, express or implied, regarding its accuracy or completeness. Before making or refraining from making any decisions based on the information provided on our website, you should seek professional or specialized advice.